JOSEPH SIEBENTHAL: Open Payments
NPI 1043889355 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 25 payments from 14 companies in 2025. Trend: 2023 $196 · 2024 $489 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Amgen Inc. | 4 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
Products named: REXULTI, Kerendia, Veozah, XIFAXAN, MOUNJARO, OTEZLA, JARDIANCE, VOQUEZNA.
Industry payments across NM — which companies pay providers there.
